NasdaqGS - Nasdaq Real Time Price USD

Gossamer Bio, Inc. (GOSS)

1.2600
+0.0400
+(3.29%)
As of 1:41:02 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
124,590
114,701
0
0
0
Operating Expense
179,360
174,620
173,759
218,528
216,049
Operating Income
-54,770
-59,919
-173,759
-218,528
-216,049
Net Non Operating Interest Income Expense
-9,405
-9,738
-11,514
-12,297
-18,679
Other Income Expense
13,830
14,022
5,456
1,447
724
Pretax Income
-50,345
-55,635
-179,817
-229,378
-234,004
Tax Provision
--
893
0
0
--
Net Income Common Stockholders
-51,238
-56,528
-179,817
-229,378
-234,004
Diluted NI Available to Com Stockholders
-51,238
-56,528
-179,817
-229,378
-234,004
Basic EPS
-0.22
-0.25
-1.18
-2.71
-3.13
Diluted EPS
-0.22
-0.25
-1.18
-2.71
-3.13
Basic Average Shares
226,498.7200
226,228.0160
152,621.6690
84,574.8690
74,843.4820
Diluted Average Shares
226,498.7200
226,228.0160
152,621.6690
84,574.8690
74,843.4820
Total Operating Income as Reported
-54,770
-59,919
-183,759
-218,593
-216,124
Total Expenses
179,360
174,620
173,759
218,528
216,049
Net Income from Continuing & Discontinued Operation
-51,238
-56,528
-179,817
-229,378
-234,004
Normalized Income
-51,238
-56,528
-169,817
-229,313
-233,929
Interest Income
1,729
1,779
1,997
1,583
761
Interest Expense
11,134
11,517
13,511
13,880
19,440
Net Interest Income
-9,405
-9,738
-11,514
-12,297
-18,679
EBIT
-39,211
-44,118
-166,306
-215,498
-214,564
EBITDA
-35,704
-39,967
-161,921
-211,069
-209,397
Reconciled Depreciation
3,507
4,151
4,385
4,429
5,167
Net Income from Continuing Operation Net Minority Interest
-51,238
-56,528
-179,817
-229,378
-234,004
Total Unusual Items Excluding Goodwill
0
0
-10,000
-65
-75
Total Unusual Items
0
0
-10,000
-65
-75
Normalized EBITDA
-35,704
-39,967
-151,921
-211,004
-209,322
Tax Rate for Calcs
0
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/8/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

STOK Stoke Therapeutics, Inc.
11.00
+0.91%
 
DTIL Precision BioSciences, Inc.
5.03
-2.33%
 
ALEC Alector, Inc.
1.5494
+4.69%
 
KZR Kezar Life Sciences, Inc.
4.3201
-1.59%
 
PASG Passage Bio, Inc.
0.4998
+0.17%
 
TRVI Trevi Therapeutics, Inc.
6.25
+5.04%
 
KROS Keros Therapeutics, Inc.
14.96
+0.03%
 
AKRO Akero Therapeutics, Inc.
53.10
+2.89%
 
CTMX CytomX Therapeutics, Inc.
2.5650
-3.21%
 
BDTX Black Diamond Therapeutics, Inc.
2.5350
+1.40%